文献速递脑血管病

血清S1P水平与脑缺血严重程度及预后相关

Serum Sphingosine-1-Phosphate Levels Are Associated With Severity and Outcome in Patients With Cerebral Ischemia.
PubMed 文献 · Stroke · 2021-09-09

在MARK-STROKE前瞻性队列374例急性缺血性卒中或TIA患者中,入院时低血清S1P与较高NIHSS评分和前循环非腔隙性梗死相关;随访294±170天,最低三分位(<1.33 µmol/L)不良事件更多,校正后HR 0.51(95%CI 0.28-0.92)。独立CIRCULAS队列219例验证了低S1P与较高NIHSS、较大梗死体积及90天更差预后相关。

要点

  • 低血清S1P与急性缺血性卒中入院时较高NIHSS评分相关
  • S1P最低三分位(<1.33 µmol/L)患者随访不良事件更多
  • 独立队列验证低S1P与较大梗死体积和90天更差预后相关

核心结论

  • 低S1P水平在急性卒中中可能起不利作用,支持S1P模拟物的治疗潜力。

研究设计与样本

  • MARK-STROKE前瞻性卒中队列纳入374例急性缺血性卒中或TIA患者,平均年龄67.9±13.0岁,男性64.7%,入院时用串联质谱分析血清S1P。
  • 270例患者随访294±170天,记录79例不良事件(死亡、卒中、心肌梗死、再住院)。
  • 结果在独立CIRCULAS队列219例急性缺血性卒中患者中验证。

主要发现

  • 多变量回归分析显示低血清S1P与入院时较高NIHSS评分及前循环非腔隙性梗死相关。
  • 随访期间S1P最低三分位(<1.33 µmol/L)患者不良事件更多(Kaplan-Meier分析,P=0.048 for trend)。
  • 校正Cox回归中最低S1P三分位与更差预后相关(HR 0.51,95%CI 0.28-0.92)。
  • 验证队列中低S1P与较高NIHSS(β=-0.03,P=0.026)、较大梗死体积(β=-0.099,P=0.009)及90天更差预后(OR 0.52,95%CI 0.28-0.96)相关。

临床怎么用

  • 入院血清S1P水平可能有助于识别急性缺血性卒中严重程度高和预后不良风险较高的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The aim of this study was to examine whether sphingosine-1-phosphate (S1P) levels in patients with acute stroke are associated with stroke severity and outcome. METHODS: In a prospective stroke cohort (MARK-STROKE), 374 patients with acute ischemic stroke or transient ischemic attack were enrolled (mean age: 67.9±13.0 years, sex: 64.7% male), and serum-S1P at admission was analyzed with tandem mass spectrometry. In addition to cross-sectional analyses, 79 adverse events (death, stroke, myocardial infarction, rehospitalization) were recorded in 270 patients during follow-up. Regression analyses were adjusted for age, sex, low-density lipoprotein cholesterol, and vascular risk factors. Results were validated in an independent stroke cohort with 219 patients with acute ischemic stroke (CIRCULAS). RESULTS: Low serum-S1P was associated with higher National Institutes of Health Stroke Scale score at admission and with anterior circulation nonlacunar infarcts determined by multivariate regression analyses. During a follow-up of 294±170 days, patients with S1P in the lowest tertile (<1.33 µmol/L) had more adverse events (Kaplan-Meier analysis, P=0.048 for trend). In adjusted Cox regression analysis, the lowest S1P tertile was associated with a worse outcome after stroke (hazard ratio, HR 0.51 [95% confidence interval 0.28-0.92]). Results were confirmed in an independent cohort, ie, low S1P levels were associated with higher National Institutes of Health Stroke Scale, larger infarct volumes and worse outcome after 90 days (β-coefficient: -0.03, P=0.026; β-coefficient: -0.099, P=0.009 and odds ratio 0.52 [0.28-0.96], respectively). CONCLUSIONS: Our findings imply a detrimental role of low S1P levels in acute stroke and therefore underpin the therapeutic potential of S1P-mimics.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Schwedhelm E, Schwieren L, Tiedt S, et al. Serum Sphingosine-1-Phosphate Levels Are Associated With Severity and Outcome in Patients With Cerebral Ischemia. Stroke. 2021. PMID: 34496616. doi:10.1161/STROKEAHA.120.033414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。